Anglia Pharma

Anglia Pharma is a specialty pharmaceutical company based in the United Kingdom, operating as a subsidiary of Advanz Pharma. The company focuses on the acquisition, licensing, and distribution of established, off-patent medicines, particularly niche products that are essential for patient care but no longer protected by patents. As a Marketing Authorisation Holder for several legacy brands, Anglia Pharma manages a portfolio that includes critical treatments for endocrine disorders, such as liothyronine and levothyroxine. The company leverages the global commercial and regulatory infrastructure of its parent organization to ensure the reliable supply of mature pharmaceutical products across the UK and European markets. Its business model emphasizes life-cycle management and the maintenance of high-quality standards for established therapies.